Gyanshankar Mishra

We are pleased to share our Spring 2026 newsletter🌱 Discover the latest updates on airborne IPC here: mailchi.mp/2aa301539a60/e… Don't want to miss the newsletter next time?! #SignUp here: stoptb.org/etti-subscribe…

Exciting news! The results of phase 3 trial for VPM1002 is now published. ‘Post hoc analyses showed vaccine efficacy of 64.6% ….. against all forms of TB, 62.1% ….. pulmonary TB, and 77.6% EPTB in 6-14 years age group in the VPM1002 group’ bmj.com/content/393/bm…

@_NSSIndia @MuhsPro Celebrating #WorldTBDay2026 at IGGMC Nagpur! A collaborative #NSS activity by Depts of Respiratory Medicine & PSM. MBBS & PG students oriented on the historical journey of TB, Airborne Infection Control, and registering as #NikshayMitra "Yes! We can end TB."

On #WorldTBDay: Correct prescribing matters in TB care. The PRAMAN India Study examines TB treatment in non-programmatic settings across India over three decades (1990–2024). Presented at APRC 2026. More: sites.google.com/smpalmaarifalu… #EndTB #Tuberculosis

Join the End TB Transmission Initiative for an engaging webinar that brings together experts to share innovative approaches to preventing airborne TB transmission, particularly in resource-limited settings. 📅 26 March 2026 ⏰ 2-3 PM CET 📍 Register: share.google/euAhsgSe9zZmUr…

DR-TB in India: A Policy Brief and Call for Action The brief draws on insights from clinicians, TB survivors, and public health experts to highlight critical gaps in the current response and outline key priorities for policymakers, including strengthening early diagnosis, improving treatment support, addressing stigma, and expanding social protection for affected households. @TbDivision @UNOPS @StopTB

From medical journals to national policy! 📄➡️🏥 ​India’s NEDL 2025 has officially integrated TDM and ADA, fixing critical diagnostic gaps in the war against TB. A massive victory for evidence-based medicine! ​Learn more here: youtube.com/watch?v=8G83XP… ​#India #MedicalNews

Presented the PRAMAN India Study findings at #APRC2026 — India’s first meta-analysis of anti-tuberculosis prescription practices in non-programmatic, real-world settings across three decades. Evidence from routine care matters for policy and practice. #PRAMANIndia #TB #India

Medicines need guidance and antibiotics must be taken only on a doctor's advice. #MannKiBaat

Can DLCO refine phenotyping in Asthma–COPD overlap? Our study shows DLCO meaningfully differentiates ACO phenotypes and correlates with symptom burden and outcomes—beyond spirometry alone. 📄 Study from India ⬇️ doi.org/10.7860/JCDR/2… #Pulmonology #ACO #DLCO #COPD #Asthma

@TheUnion_TBLH Looking forward to APRC 2026 in Bangkok. I will be presenting an oral presentation on anti-tuberculosis prescription practices in non-programmatic settings from India, along with a poster on post-tuberculosis lung disease.

The 2026 Asia Pacific regional conference, co-hosted by our Asia Pacific regional membership group, is being held in Bangkok, Thailand February 2026. Abstract submission is now open. To get more information about this event, please visit: aprc2026.org

🎉Celebrating the brilliant mind of Robert Koch on his birthday! Born on December 11, 1843, his groundbreaking work in microbiology changed the world. His discovery of the TB bacilli earned him the Nobel Prize, forever transforming our understanding of disease. 📷#RobertKoch #TB

Honoured to share that my abstract “Dispensing Change: The PRAMAN India Study (1990–2024)” has been accepted for presentation at APRC 2026, Bangkok 🌏🫁 This is India’s first-ever meta-analysis of TB prescription practices in non-programmatic settings over 3 decades. #TB

Read about the latest updates from TB and airborne IPC in ETTi November Newsletter: mailchi.mp/40584890d719/e… Subscribe to ETTi newsletter: stoptb.org/etti-subscribe…

India’s fight against TB is achieving remarkable momentum. The latest WHO Global tuberculosis report 2025 highlights that India has recorded a commendable reduction in TB incidence since 2015 and it is nearly twice the global rate of decline. This is one of the sharpest drops seen anywhere in the world. Equally heartening is the expansion of treatment coverage, the fall in ‘missing cases’ and the sustained rise in treatment success. I compliment all those who have worked towards achieving this success. We remain committed to ensuring a healthy and fit India! pib.gov.in/PressReleasePa… @WHO

@aiims_newdelhi WHO has already published policy guidelines on"Use of computer-aided detection software for tuberculosis screening" on 10 June 2025: who.int/publications/i…

The Department of Radiology at AIIMS Delhi uses a clinically approved AI algorithm to triage chest radiographs. If any discrepancy is noticed in the AI results, a radiologist reviews the X-ray, along with the routine review of select positive radiographs.

Honoured to be featured in the ETTi Nov 2025 Newsletter ✨ This issue highlights key developments in TB transmission prevention, new IPC tools, and global member work. A must-read for TB & IPC teams. 🔗 mailchi.mp/40584890d719/e… #EndTB #IPC #ETTi #GlobalHealth #TBFreeIndia

@StopTB_ETT @StopTB Grateful to @StopTB_ETT for spotlighting this session. Most participants were program supervisors working directly with people affected by TB, including drug-resistant TB—bringing infection control practices straight to the frontline. #TB #HCW

On 29 Oct. Dr. Gyanshankar Mishra, Associate Professor at IGGMCH Nagpur and ETTi Core Group Member, conducted a training on TB risk and airborne infection control for 30 healthcare workers from across Maharashtra. It emphasized practical AIC measures and use of N95 respirators.

International Journal of Infection Control published the article “Knowledge gaps and research priorities for understanding the transmission of Mycobacterium tuberculosis and other airborne infections,” initiated by ETTi and led by author Peter Cegielski. ijic.info/article/view/2…